@kmartfit's testosterone therapy pros and cons, reviewed

What did @kmartfit actually say?

The creator runs through three fears men have about testosterone replacement therapy: that TRT is a lifelong commitment you can't exit, that it destroys fertility, and that it causes permanent testicular atrophy. His framing is that all three are myths. He credits enclomiphene, a medication he personally takes, as the fix for both fertility preservation and testicular size. He closes by funneling viewers toward a specific telehealth clinic, asking them to comment "TRT" to get the referral link.

Credit where it's due: he's addressing real concerns that do keep men from seeking care. But "that is just not the case" and "that is a myth" are doing a lot of heavy lifting for claims that are considerably more complicated than he presents them.

Does the science back this up?

Partially, but the confidence level here is higher than the evidence warrants. On fertility: exogenous testosterone does suppress the hypothalamic-pituitary-gonadal (HPG) axis, which reduces sperm production. Enclomiphene, a selective estrogen receptor modulator, can help preserve LH and FSH signaling while on TRT. That part is real. But it's not a guaranteed fertility shield, and calling the fertility risk a "myth" misrepresents the biology.

On testicular atrophy: testosterone suppresses LH, which in turn reduces intratesticular testosterone and Leydig cell stimulation. Testicular volume loss is a documented, common side effect. Ramasamy et al. (2015, Urology) reported testicular volume loss in men on exogenous testosterone. Enclomiphene may mitigate this, but the creator's claim that "nothing has shrank" is anecdotal and not generalizable.

On stopping TRT: recovery of endogenous testosterone production is possible, especially in younger men with shorter treatment durations, but it is not guaranteed. Khera et al. (2016, Journal of Urology) noted that recovery timelines vary widely and some men experience prolonged hypogonadism after cessation.

What did they get wrong (or right)?

The fertility claim is the most misleading moment. He says infertility from TRT is "a myth," which flattens a documented clinical risk into a non-issue. The American Urological Association's 2018 guidelines explicitly list azoospermia as a risk of exogenous androgen use. That's not a myth. It's a reason fertility-conscious men on TRT need co-management, not reassurance that the risk doesn't exist.

He gets partial credit for mentioning enclomiphene as a co-treatment. Enclomiphene citrate has shown promise in maintaining gonadotropin levels during TRT. Wiehle et al. (2014, Aging Male) showed it preserved LH and FSH in men receiving exogenous androgens. However, framing it as a blanket solution for every man's fertility concerns overstates the evidence.

The "stuck on it for life" claim is also more complicated than he lets on. Some men do recover baseline testosterone after stopping, but the idea that supplements can reliably "taper you off" lacks clinical support. What supplements? At what doses? The vagueness here is a red flag, not a reassurance.

What should you actually know?

TRT involves real trade-offs that deserve honest conversation, not myth-busting that swings too far in the other direction. Testicular atrophy is common. Fertility suppression is real. Recovery after stopping is variable and sometimes slow. None of this means TRT is a bad choice for men with documented hypogonadism. It means the decision should involve an actual physician, baseline hormone labs, and a conversation about your reproductive goals before you start.

Enclomiphene is a legitimate tool in this space, but it's not universally prescribed, it's not FDA-approved for this specific use in combination with TRT, and its long-term efficacy data in this context is still limited. If you're considering TRT and care about fertility or testicular function, bring those concerns to a provider who can order a semen analysis and monitor you, not a TikTok comment thread.

The referral pitch at the end is also worth naming: this video is structured as content marketing for a specific clinic. That doesn't make the information wrong, but it's context you should have when evaluating the confidence with which these claims are delivered.

What's the bottom line?

The creator identifies real concerns men have, and some of his points are directionally correct. But calling documented side effects "myths" and presenting enclomiphene as a complete solution overpromises on both counts. The science says these risks are manageable with proper monitoring, not that they don't exist. That's an important distinction, especially for men making decisions about their hormones and reproductive health based on a 60-second TikTok.